Sarah A. Teichmann
Director at 10x Genomics, Inc. (TXG)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $579K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 17SEC | TXG10x Genomics, Inc. | Sell Plan | 5,27830,331 held (−15%) | $57.29 | $302K | +21.9% |
| Aug 17SEC | TXG10x Genomics, Inc. | Sell Plan | 2,27328,058 held (−7%) | $57.15 | $130K | +22.2% |
| Feb 27SEC | TXG10x Genomics, Inc. | Sell Plan | 7,57926,780 held (−22%) | $19.41 | $147K | +259.9% |
- Sell
Director Sarah A. Teichmann sold $302K of TXG at $57.29 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Sarah A. Teichmann sold $130K of TXG at $57.15 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Sarah A. Teichmann sold $147K of TXG at $19.41 — pre-scheduled 10b5-1 plan sale.